← Leaderboards
Christos Vaklavas
University Of Utah
$195,449
Attributed
$390,897
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $211.5K · FY2022–23$250K$187.5K$125K$62.5K$0
'22
'23
Funding mix
By agency
NIH$390,897 · 1
By mechanism
R21$390,897 · 1
Top collaborators
- Alana L Welm2 shared
Most similar at University Of Utah
Same institution · by research overlap
- Ignacio Garrido-Laguna$3,846,099
- Grant J Jensen$18,127,842
- Jason Michael Tennessen$5,603,606
- Josh Leitch Bonkowsky$6,570,963
- Jay W. Mason$674,939
Others in their field
Other Rising Stars on “Actionable Mutation”
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Robert W Cross · University Of Texas Med Br Galveston$4,640,498
- Seunghee Kim-Schulze · Icahn School Of Medicine At Mount Sinai$2,933,846
- Raul Padron · Univ Of Massachusetts Med Sch Worcester$2,818,630
- Nicholas Schafer · Constantiam Biosciences Inc.$2,445,923
- Alison F Feder · University Of Washington$2,326,574
Research focus
Actionable MutationExhibitsBiologic CharacteristicBiopsyClinical EfficacyBiologicalClinically RelevantClinical PracticeClinical PredictorsClinical TreatmentClinical TrialsCombinatorialComplexDesignDisease RemissionDouble-Blind MethodDrug ScreeningEcosystemEffective TherapyEndocrineEnrollmentErbb2 GeneExhaustFeasibility Trial
Grant awards (2)
A feasibility trial of functional precision cancer medicine to inform treatment selection in metastatic breast cancer$211,494
R21 · FY2023 · CA · contact PI
A feasibility trial of functional precision cancer medicine to inform treatment selection in metastatic breast cancer$179,403
R21 · FY2022 · CA · contact PI